Stocktoria
Oaktree Acquisition Corp. III Life Sciences OACC
Nasdaq · XNAS · stock · Blank Checks · IPO 2024-12-16
Oaktree Acquisition Corp. III Life Sciences financials (annual, from 10-K)
| Metric | FY2025 |
|---|---|
| Operating income | -$1.2M |
| Net income | $7.3M |
| Operating cash flow | -$422,079 |
| Cash & equivalents | $1.4M |
| Total assets | $203.1M |
| Total liabilities | $8.3M |
| Shareholders' equity | -$6.8M |
Source: SEC EDGAR filings · CIK 0002029769 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.